Metavia INC Form 4 insider transactions
NASDAQ
MTVA
Metavia INCForm 4: NeuroBo Pharmaceuticals Director James Patrick Tursi Reports Changes in Beneficial Ownership
Director James Patrick Tursi reports acquisition and disposal of NeuroBo Pharmaceuticals common stock and restricted stock units.
NASDAQ
MTVA
Metavia INCMarshall H. Woodworth, CFO of NeuroBo Pharmaceuticals, was granted 33,496 restricted stock units (RSUs) under the company's 2022 Equity Incentive Plan.